Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)
5.37
-0.03 (-0.56%)
At close: Apr 29, 2026
HKG:6922 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Net Income | - | -104.37 | -97.49 | -112.22 | -101.87 | Upgrade
|
| Depreciation & Amortization | - | 11.84 | 9.41 | 7.62 | 4.47 | Upgrade
|
| Other Amortization | - | 0.02 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.01 | - | 0 | 0.11 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 9.32 | - | - | - | Upgrade
|
| Stock-Based Compensation | - | 16.53 | 19.86 | 20.45 | 17.82 | Upgrade
|
| Other Operating Activities | - | -6.28 | -8.75 | -8.6 | 24.73 | Upgrade
|
| Change in Inventory | - | -5.77 | -4.71 | -8.12 | -3.62 | Upgrade
|
| Change in Accounts Payable | - | 0.3 | -0.86 | 1.45 | 0.13 | Upgrade
|
| Change in Unearned Revenue | - | 2.14 | -2.26 | 2.38 | -5.09 | Upgrade
|
| Change in Other Net Operating Assets | - | -6.65 | -11.12 | 0.09 | 0.82 | Upgrade
|
| Operating Cash Flow | - | -82.91 | -95.89 | -96.94 | -62.49 | Upgrade
|
| Capital Expenditures | - | -1.88 | -15.1 | -7.01 | -12.44 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | -0.06 | Upgrade
|
| Investment in Securities | - | - | - | - | 24.93 | Upgrade
|
| Other Investing Activities | - | - | - | 0.46 | 3.22 | Upgrade
|
| Investing Cash Flow | - | -1.88 | -15.1 | -6.55 | 15.65 | Upgrade
|
| Short-Term Debt Issued | - | 35.74 | - | - | - | Upgrade
|
| Total Debt Issued | - | 35.74 | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -5.74 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -4.14 | -5.45 | -2.88 | -2.26 | Upgrade
|
| Total Debt Repaid | - | -9.89 | -5.45 | -2.88 | -2.26 | Upgrade
|
| Net Debt Issued (Repaid) | - | 25.86 | -5.45 | -2.88 | -2.26 | Upgrade
|
| Issuance of Common Stock | - | - | - | 187.52 | 204.38 | Upgrade
|
| Other Financing Activities | - | -0.39 | -8.24 | -15.24 | -4.37 | Upgrade
|
| Financing Cash Flow | - | 25.47 | -13.68 | 169.4 | 197.75 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 1.38 | 1.66 | 2.64 | -0.53 | Upgrade
|
| Net Cash Flow | - | -57.94 | -123.02 | 68.56 | 150.38 | Upgrade
|
| Free Cash Flow | - | -84.79 | -111 | -103.95 | -74.93 | Upgrade
|
| Free Cash Flow Margin | - | -158.39% | -271.05% | -382.87% | -334.11% | Upgrade
|
| Free Cash Flow Per Share | - | -0.35 | -0.46 | -0.46 | -0.33 | Upgrade
|
| Cash Interest Paid | - | 0.39 | - | - | - | Upgrade
|
| Cash Income Tax Paid | - | 0.13 | - | - | - | Upgrade
|
| Levered Free Cash Flow | - | -65.39 | -85.44 | -49.02 | -49.42 | Upgrade
|
| Unlevered Free Cash Flow | - | -64.71 | -85.03 | -48.65 | -49.19 | Upgrade
|
| Change in Working Capital | - | -9.98 | -18.94 | -4.2 | -7.76 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.